Bloomberg News

Allscripts Falls After Quarterly Sales Miss Analysts’ Estimates

May 09, 2013

Allscripts Inc., the electronic medical records provider, declined 8.3 percent in extended trading after reporting first-quarter sales (MDRX:US) and earnings that were lower than analysts’ estimates.

Sales fell 4.8 percent to $347.1 million compared with the $368.6 million average of 14 analysts’ estimates (MDRX:US) compiled by Bloomberg. Profit excluding certain items was 9 cents a share, the Chicago-based company reported today in a statement. Analysts had estimated 15 cents a share.

The company in December fired Glen Tullman as chief executive officer and replaced him with a director, Paul Black, after a year marked by board turmoil, a shareholder revolt and a failed effort to sell itself to private equity buyers. Black called 2013 a “rebuilding” year for the company, which sells its products to doctors, hospitals and other health-care providers.

“We are investing heavily in both our clients and our products and so while our financial results for the quarter are not surprising, they are not satisfactory and not indicative of our long-term potential,” Black said in the statement.

Allscripts reported a first-quarter net loss (MDRX:US) of $11.6 million, or 7 cents a share, from a profit of $5.8 million, or 3 cents, a year earlier.

The company’s shares declined to $12.70 in extended trading at 4:39 p.m. New York time after closing at $13.85. The shares have gained 28 percent in the past 12 months.

To contact the reporter on this story: Alex Wayne in Washington at

To contact the editor responsible for this story: Reg Gale at

Toyota's Hydrogen Man

Companies Mentioned

  • MDRX
    (Allscripts Healthcare Solutions Inc)
    • $12.74 USD
    • 0.31
    • 2.43%
Market data is delayed at least 15 minutes.
blog comments powered by Disqus